FDA Approves Oveporexton for NT1, Grants RMAT Designation to Sasineprocel in PD, Emerging Literature in Spinal Muscular Atrophy
FDA Approves Oveporexton for NT1, Grants RMAT Designation to Sasineprocel in PD, Emerging Literature in Spinal Muscular Atrophy NeurologyLive